VMP1缺失损害肝脏脂蛋白分泌并促进非酒精性脂肪性肝炎
本研究通过肝细胞特异性Vmp1敲除与敲入小鼠及代谢组、转录组分析,发现VMP1缺失严重损害VLDL分泌,导致肝脏大量脂肪变性、肝细胞死亡、炎症和纤维化等NASH特征;VMP1过表达可改善饮食诱导的NASH;人类NAFLD/NASH中肝脏VMP1降低。
要点
- 肝细胞特异性Vmp1缺失损害VLDL分泌,导致肝脏大量脂肪变性及NASH特征。
- VMP1过表达通过改善VLDL分泌减轻饮食诱导的NASH。
- 人类NAFLD/NASH中肝脏VMP1水平降低。
核心结论
- VMP1通过调控肝脏磷脂合成和脂蛋白分泌参与NAFLD/NASH发病机制。
研究设计与样本
- 研究为动物实验,采用肝细胞特异性Vmp1敲除小鼠、Vmp1敲入小鼠及肝脏过表达VMP1的小鼠,并进行代谢组和转录组分析。
主要发现
- 肝细胞特异性Vmp1缺失严重损害VLDL分泌,导致肝脏大量脂肪变性、肝细胞死亡、炎症和纤维化。
- Vmp1缺失导致肝脏磷脂酰胆碱和磷脂酰乙醇胺水平降低及磷脂组成改变。
- Vmp1缺失导致中性脂质在内质网双层中积累并损害线粒体β氧化。
- VMP1过表达通过改善VLDL分泌减轻饮食诱导的NASH。
- 人类NAFLD/NASH中肝脏VMP1降低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Vacuole membrane protein 1 (VMP1) is an endoplasmic reticulum (ER) transmembrane protein that regulates the formation of autophagosomes and lipid droplets. Recent evidence suggests that VMP1 plays a critical role in lipoprotein secretion in zebra fish and cultured cells. However, the pathophysiological roles and mechanisms by which VMP1 regulates lipoprotein secretion and lipid accumulation in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are unknown. METHODS: Liver-specific and hepatocyte-specific Vmp1 knockout mice as well as Vmp1 knock-in mice were generated by crossing Vmp1flox or Vmp1KI mice with albumin-Cre mice or by injecting AAV8-TBG-cre, respectively. Lipid and energy metabolism in these mice were characterized by metabolomic and transcriptome analyses. Mice with hepatic overexpression of VMP1 who were fed a NASH diet were also characterized. RESULTS: Hepatocyte-specific deletion of Vmp1 severely impaired VLDL secretion resulting in massive hepatic steatosis, hepatocyte death, inflammation and fibrosis, which are hallmarks of NASH. Mechanistically, loss of Vmp1 led to decreased hepatic levels of phosphatidylcholine and phosphatidylethanolamine as well as to changes in phospholipid composition. Deletion of Vmp1 in mouse liver also led to the accumulation of neutral lipids in the ER bilayer and impaired mitochondrial beta-oxidation. Overexpression of VMP1 ameliorated steatosis in diet-induced NASH by improving VLDL secretion. Importantly, we also showed that decreased liver VMP1 is associated with NAFLD/NASH in humans. CONCLUSIONS: Our results provide novel insights on the role of VMP1 in regulating hepatic phospholipid synthesis and lipoprotein secretion in the pathogenesis of NAFLD/NASH. LAY SUMMARY: Non-alcoholic fatty liver disease and its more severe form, non-alcoholic steatohepatitis, are associated with a build-up of fat in the liver (steatosis). However, the exact mechanisms that underly steatosis in patients are not completely understood. Herein, the authors identified that the lack of a protein called VMP1 impairs the secretion and metabolism of fats in the liver and could therefore contribute to the development and progression of non-alcoholic fatty liver disease.
引用
- Jiang X, Fulte S, Deng F, et al. Lack of VMP1 impairs hepatic lipoprotein secretion and promotes non-alcoholic steatohepatitis. J Hepatol. 2022. PMID: 35452693. doi:10.1016/j.jhep.2022.04.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。